Anavex Life Sciences Corp 2024年度报告

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 10-K (Mark One) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGEACT OF 1934 For the fiscal year endedSeptember 30, 2024 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period from ______________ to________________ Commission file number:001-37606 ANAVEX LIFE SCIENCES CORP.(Exact name of registrant as specified in its charter) Nevada98-0608404(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.) 630 5th Avenue, 20th Floor, New York, NY USA10111(Address of principal executive offices)(Zip Code) Registrant’s telephone number, including area code1-844-689-3939 Securities registered under Section 12(b) of the Act: Common Stock, $0.001 par valueAVXLNASDAQ Stock Market LLCTitle of each classTrading SymbolName of each exchange on which registered Securities registered pursuant to Section 12(g) of the Act: None(Title of class) Indicate by checkmark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes☒No☐ Indicate by checkmark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes☐No☒ Indicate by checkmark whether the registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file suchreports), and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe registrant was required to submit and post such files).Yes☒No☐ Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smallerreporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of theeffectiveness of its internal controls over financial reporting under Section404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b))by the registered public accounting firm that prepared or issued its audit report.Yes☐No☒ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of theregistrant included in the filing reflect the correction of an error to previously issued financial statements☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to theprice at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last businessday of the registrant’s most recently completed second fiscal quarter: $412 million based on a price of $5.09 per share, being theclosing price of the registrant’s common stock on March 31, 2024. Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date:84,815,517 issued and outstanding as of December 23, 2024. None. TABLE OF CONTENTS PART I.........................................................................................................................................................................................6ITEM 1. BUSINESS...................................................................................................................................................................6ITEM 1A. RISK FACTORS.......................................................................................................................................................29ITEM 1B. UNRESOLVED STAFF COMMENTS..........................................................................................................